Safety and efficacy of first-line nivolumab plus chemotherapy for HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: real-world data analysis
| Autor: | Shimozaki, K., Fukuda, K., Ooki, A., Nakayama, I., Yoshino, K., Tamba, M., Udagawa, S., Fukuoka, S., Osumi, H., Wakatsuki, T., Takahari, D., Shinozaki, E., Ogura, M., Chin, K., Yamaguchi, K. |
|---|---|
| Zdroj: | In ESMO Gastrointestinal Oncology September 2024 5 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|